{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:46:10Z","timestamp":1764002770737,"version":"3.40.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clinre.2024.102470","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T15:25:37Z","timestamp":1727105137000},"page":"102470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Co-exposure to different bacterial species\u2019 lipopolysaccharides with the NASH diet exacerbates NASH and liver fibrosis progression in mice"],"prefix":"10.1016","volume":"48","author":[{"given":"Yen-Peng","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Chao","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Chi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hsun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3718-9076","authenticated-orcid":false,"given":"Hsiao-Li","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2024.102470_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0002","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2024.102470_bib0003","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","author":"Takahashi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102470_bib0004","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102470_bib0005","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1365-2982.2008.01142.x","article-title":"Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress","volume":"20","author":"Grover","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.clinre.2024.102470_bib0006","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0007","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.3390\/ijms22158161","article-title":"The role of leaky gut in nonalcoholic fatty liver disease: a novel therapeutic target","volume":"22","author":"Kessoku","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2024.102470_bib0008","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10620-015-3977-1","article-title":"Animal Models of nonalcoholic steatohepatitis: eat, delete, and inflame","volume":"61","author":"Ibrahim","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2024.102470_bib0009","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2613.2011.00793.x","article-title":"Pathology of the liver in obese and diabetic ob\/ob and db\/db mice fed a standard or high-calorie diet","volume":"92","author":"Trak-Smayra","year":"2011","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.clinre.2024.102470_bib0010","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","article-title":"Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment","volume":"305","author":"Clapper","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.clinre.2024.102470_bib0011","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","article-title":"Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: impact of dietary fat source","volume":"25","author":"Boland","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102470_bib0012","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/biomedicines8020028","article-title":"NAFLD preclinical models: more than a handful, less of a concern?","volume":"8","author":"Oligschlaeger","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinre.2024.102470_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6489012","article-title":"Role of NLRP3 inflammasome in the progression of NAFLD to NASH","volume":"2016","author":"Wan","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-9255-7-15","article-title":"Elevated endotoxin levels in non-alcoholic fatty liver disease","volume":"7","author":"Harte","year":"2010","journal-title":"J Inflamm"},{"key":"10.1016\/j.clinre.2024.102470_bib0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102470_bib0016","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102470_bib0017","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","article-title":"An update on the regulatory mechanisms of NLRP3 inflammasome activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.clinre.2024.102470_bib0018","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss","volume":"39","author":"Dixon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102470_bib0019","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102470_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","article-title":"Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by Leptin-mediated signaling","volume":"16","author":"Imajo","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.clinre.2024.102470_bib0021","doi-asserted-by":"crossref","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","article-title":"IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples","volume":"9","author":"Varghese","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinre.2024.102470_bib0022","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102470_bib0023","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2010.04.031","article-title":"Hepatocellular ballooning in NASH","volume":"53","author":"Caldwell","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0024","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1440-1746.2008.05543.x","article-title":"Animal models of NASH: getting both pathology and metabolic context right","volume":"23","author":"Larter","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0026","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1177\/0300060519833527","article-title":"Pathogenesis of and major animal models used for nonalcoholic fatty liver disease","volume":"47","author":"Jiang","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clinre.2024.102470_bib0027","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s10620-018-5395-7","article-title":"Disease progression and pharmacological intervention in a nutrient-deficient rat model of nonalcoholic steatohepatitis","volume":"64","author":"T\u00f8lb\u00f8l","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2024.102470_bib0028","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"22","author":"Hansen","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.clinre.2024.102470_bib0029","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/1440-1681.12102","article-title":"A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice","volume":"40","author":"Kubota","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.clinre.2024.102470_bib0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12876-020-01356-2","article-title":"Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Hansen","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102470_bib0031","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.3390\/ijms20112724","article-title":"Exogenous administration of low-dose lipopolysaccharide potentiates liver fibrosis in a choline-deficient l-amino-acid-defined diet-induced murine steatohepatitis model","volume":"20","author":"Nakanishi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2024.102470_bib0032","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.clinre.2024.102470_bib0033","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/osp4.476","article-title":"Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease","volume":"7","author":"Behari","year":"2021","journal-title":"Obes Sci Pract"},{"key":"10.1016\/j.clinre.2024.102470_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126976","article-title":"Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice","volume":"10","author":"Moya-P\u00e9rez","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinre.2024.102470_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1110536","article-title":"Gut microbiota modulation in patients with non-alcoholic fatty liver disease: effects of current treatments and future strategies","volume":"10","author":"Maestri","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.clinre.2024.102470_bib0036","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcmgh.2015.01.001","article-title":"Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability","volume":"1","author":"Luther","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0037","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chom.2017.11.004","article-title":"Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration","volume":"23","author":"Schroeder","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clinre.2024.102470_bib0038","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0039","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.cgh.2022.11.030","article-title":"Blood endotoxin levels as biomarker of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Soppert","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03263-19","article-title":"Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease","volume":"11","author":"Fei","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.clinre.2024.102470_bib0041","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.micinf.2005.10.006","article-title":"The role of lipopolysaccharide-binding protein in modulating the innate immune response","volume":"8","author":"Zweigner","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.clinre.2024.102470_bib0042","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/cancers13040730","article-title":"Inflammatory mechanisms underlying nonalcoholic steatohepatitis and the transition to hepatocellular carcinoma","volume":"13","author":"Peiseler","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clinre.2024.102470_bib0043","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.30252","article-title":"NLR family pyrin domain- containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice","volume":"69","author":"Inzaugarat","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102470_bib0044","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3390\/cells9102148","article-title":"The absence of NLRP3-inflammasome modulates hepatic fibrosis progression, lipid metabolism, and inflammation in KO NLRP3 mice during aging","volume":"9","author":"Gallego","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.clinre.2024.102470_bib0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J Mol Med"},{"key":"10.1016\/j.clinre.2024.102470_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.102056","article-title":"Inhibition of hepatic NLRP3 inflammasome ameliorates non-alcoholic steatohepatitis\/hepatitis B-induced hepatic injury","volume":"47","author":"Chen","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102470_bib0047","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"IT-LIVER consortium. TGF-\u03b2 signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.clinre.2024.102470_bib0048","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2024.102470_bib0049","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/19490976.2019.1681861","article-title":"Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis","volume":"11","author":"Astbury","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.clinre.2024.102470_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244763","article-title":"Modeling dysbiosis of human NASH in mice: loss of gut microbiome diversity and overgrowth of Erysipelotrichales","volume":"16","author":"Carter","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinre.2024.102470_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1110536","article-title":"Gut microbiota modulation in patients with non-alcoholic fatty liver disease: effects of current treatments and future strategies","volume":"10","author":"Maestri","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.clinre.2024.102470_bib0052","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/biomedicines11041097","article-title":"Non-alcoholic fatty liver disease or type 2 diabetes mellitus-the chicken or the egg dilemma","volume":"11","author":"Kosmalski","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinre.2024.102470_bib0053","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.numecd.2017.10.014","article-title":"Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: a prospective pilot study","volume":"28","author":"Duarte","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.clinre.2024.102470_bib0054","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0168-8278(03)00097-7","article-title":"Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics","volume":"38","author":"Solga","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2024.102470_bib0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40139-015-0093-z","article-title":"TNF\u03b1 in liver fibrosis","volume":"3","author":"Yang","year":"2015","journal-title":"Curr Pathobiol Rep"},{"key":"10.1016\/j.clinre.2024.102470_bib0056","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat Commun"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T18:32:46Z","timestamp":1731522766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2210740124001918"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102470","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-exposure to different bacterial species\u2019 lipopolysaccharides with the NASH diet exacerbates NASH and liver fibrosis progression in mice","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102470"}}